“A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer”

BACKGROUND: The European Randomized study of Screening for Prostate Cancer (ERSPC) has previously demonstrated that prostate-specific antigen (PSA) screening decreases prostate cancer (PCa) mortality. OBJECTIVE: To determine whether PSA screening decreases PCa mortality for up to 16 yr and to assess...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Eur Urol
Main Authors: Hugosson, Jonas, Roobol, Monique J., Månsson, Marianne, Tammela, Teuvo L.J., Zappa, Marco, Nelen, Vera, Kwiatkowski, Maciej, Lujan, Marcos, Carlsson, Sigrid V., Talala, Kirsi M., Lilja, Hans, Denis, Louis J., Recker, Franz, Paez, Alvaro, Puliti, Donella, Villers, Arnauld, Rebillard, Xavier, Kilpeläinen, Tuomas P., Stenman, Ulf H., Godtman, Rebecka Arnsrud, Kollberg, Karin Stinesen, Moss, Sue M., Kujala, Paula, Taari, Kimmo, Huber, Andreas, van der Kwast, Theodorus, Heijnsdijk, Eveline A., Bangma, Chris, de Koning, Harry J., Schröder, Fritz H., Auvinen, Anssi
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7513694/
https://ncbi.nlm.nih.gov/pubmed/30824296
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eururo.2019.02.009
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados